<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000523452"><TermName>Trisenox</TermName><TermPronunciation>(TRY-seh-nox)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat acute promyelocytic leukemia (APL) that has not gotten better or that has come back after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Also called arsenic trioxide.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718537" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Trisenox&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718536" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Trisenox&quot;" language="es" id="_4"/><SpanishTermName>Trisenox</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento usado para tratar la leucemia promielocítica aguda (LPA) que no ha mejorado o ha vuelto después del tratamiento con otros medicamentos contra el cáncer. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. También se llama trióxido de arsénico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished><DateLastModified>2006-11-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000500188">Arsenic Trioxide</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
